Tuesday, July 16, 2024 | 17:58 WIB

Takeda Supports the 2024 ADD Commemoration for Zero Dengue Deaths in Indonesia by 2030


Jakarta, IO –  Amid the recent spike in dengue fever (in Indonesia known as DBD) cases, PT Takeda Innovative Medicines is taking advantage of the momentum of commemorating 2024 ASEAN Dengue Day (ADD) to strengthen its commitment to preventing DBD by providing support to the Indonesian Ministry of Health. ADD is celebrated on June 15 every year to increase public awareness and understanding of the dangers of DBD.

Andreas Gutknecht, President Director of PT Takeda Innovative Medicines, said that DBD always becomes a threat both in rainy and dry seasons. “Everyone can get DBD regardless of age, place of residence, or even lifestyle. We are committed to fighting DBD through our innovative prevention by ensuring access is available to all people in Indonesia. In addition, establishing strong partnerships with the government and other stakeholders to achieve the common goal of ‘zero deaths from DBD by 2030’. Therefore, we thank the Ministry of Health for its continued partnership in this fight.”

Based on data from the Ministry of Health as of May 5, 2024, there were 91,269 cases of DBD in Indonesia with 641 deaths. This figure has tripled compared to the same period in 2023, namely 28,579 cases with 209 deaths.

Director of Prevention and Control of Infectious Diseases Ministry of Health, dr. Imran Pambudi, MPPH, expressed his appreciation to PT Takeda Innovative Medicines as a partner in fighting DBD in Indonesia. “Handling endemic diseases such as DBD requires strong synergy between government, private sector, industry and society. By the theme promoted by the government at the 2024 ADD commemoration, namely ‘Together Against DBD’, we are very open to collaborating with various parties in Indonesia to eradicate DBD.”

“We have made various efforts together, starting from implementing the sustainable 3MPlus Movement which we have carried out for more than a decade; the 1 House 1 Jumantik Movement (G1R1J) which has been proven to help reduce DBD cases in many areas; as well as implemented of the Wolbachia mosquito technology. However, the very significant increase in DBD cases at the beginning of this year is like an alarm for all of us to look for innovative solutions that can complement these efforts. What is being considered is the introduction of vaccines, especially in areas with high dengue intensity,” dr. Imran added.

According to Gutknecht, “We understand that the burden caused by DBD is very large, both financially and non-financially. For individuals and families, DBD is increasingly causing concern. Moreover, this disease is life-threatening and still exists, due there is no special medicine to treat it. Treating DBD is high cost, it usually takes 7-14 days for treatment and recovery so it can cause a person to lose productivity in the industry or company which will also experience a decrease in productivity and a fairly high increase in costs.”

Comprehensive self-protection is important to avoid the burden of this disease. “We invite all levels of society to take proactive steps by implementing the 3MPlus movement consistently and seeking as much information as possible regarding innovative prevention interventions, one of which is through vaccination. Let’s together create an environment that is safe from DBD for our children, our families, and our country,” concluded Gutknecht.

Read: Nutrition Tips To Support Body Endurance During Exercise

Meanwhile, Prof. dr. Jarir At Thobari, D.Pharm., Ph.D, professor of pharmacoepidemiology from Gadjah Mada University (UGM), Yogyakarta, explained that handling endemic diseases such as DBD in Indonesia through a vaccination could have a significant impact in reducing the number of cases and the burden of health costs. “The results of our recent cost-effectiveness study show that DBD vaccination not only saves costs from a healthcare and societal perspective but also provides substantial health benefits by reducing the number of dengue cases and hospitalizations. These findings are in line with WHO’s latest recommendations supporting the use of vaccination as part of public health programs. Let’s hope that the implementation of the DBD vaccination program in Indonesia will improve people’s quality of life and reduce the economic burden caused by this disease.”

In commemoration of 2024 ADD 2024, the Ministry of Health is holding a series of activities such as a media and blogger collection in Jakarta on 13 June and a public seminar in Batam on June 27, 2024. (*)


Latest article

Related Articles